<DOC>
	<DOCNO>NCT00190229</DOCNO>
	<brief_summary>Henoch-Schonlein purpura leucocytoclastic systemic vasculitis involve small vessel deposition immune complex contain IgA . It characterize association skin , joint gastrointestinal manifestation . Even though evolution usually simple , patient , especially adult , may severe visceral involvement include heart , lung , brain renal disease . The best treatment currently unknown . This study test safety efficacy steroid associate cyclosphosphamide treat acute lesion prevent development chronic lesion .</brief_summary>
	<brief_title>Efficacy Steroid Versus Steroid Plus Cyclophosphamide Severe Henoch-Schoenlein Purpura</brief_title>
	<detailed_description>The protocol test role 2 modality treatment ( steroid vs. steroid cyclophosphamide ) severe systemic form Henoch-Schonlein purpura . The severe form include extracapillary glomerulonephritis , myocarditis , pneumonitis , occult involvement , severe gastro-intestinal bleeding . No randomized trial perform adult patient indication .</detailed_description>
	<mesh_term>Purpura</mesh_term>
	<mesh_term>Purpura , Schoenlein-Henoch</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>Patients HenochSchoenlein purpura Patient 's age &gt; 18 year Exclusion criterion : Patient present purpura RHEUMATOID diagnosis confirm histology present least visceral infringement ( achievement ) make consider affection engraves ( burn ) 18 year old Patient Patient capable understanding ( include ) advantage risk try Patient give assent lit writing</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2007</verification_date>
	<keyword>Vasculitis</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>Renal failure</keyword>
</DOC>